|
|
||||||||||
|
J Am Coll Cardiol, 2004; 43:1731-1737, doi:10.1016/j.jacc.2003.12.047 © 2004 by the American College of Cardiology Foundation |

* Comprehensive Cardiovascular Center, Saint Vincent Catholic Medical Centers of New York, New York Medical College, New York, New York, USA
Department of Medicine, the Bronx Veteran Affairs Medical Center, Mount Sinai School of Medicine, New York, New York, USA
Manuscript received September 24, 2003; revised manuscript received December 18, 2003, accepted December 23, 2003.
* Reprint requests and correspondence: Dr. John A. Ambrose, The Comprehensive Cardiovascular Center, Saint Vincent Catholic Medical Centers of New York, 170 West 12th Street, New York, New York 10011, USA.
jamambrose{at}yahoo.com
Cigarette smoking (CS) continues to be a major health hazard, and it contributes significantly to cardiovascular morbidity and mortality. Cigarette smoking impacts all phases of atherosclerosis from endothelial dysfunction to acute clinical events, the latter being largely thrombotic. Both active and passive (environmental) cigarette smoke exposure predispose to cardiovascular events. Whether there is a distinct direct dose-dependent correlation between cigarette smoke exposure and risk is debatable, as some recent experimental clinical studies have shown a non-linear relation to cigarette smoke exposure. The exact toxic components of cigarette smoke and the mechanisms involved in CS-related cardiovascular dysfunction are largely unknown, but CS increases inflammation, thrombosis, and oxidation of low-density lipoprotein cholesterol. Recent experimental and clinical data support the hypothesis that cigarette smoke exposure increases oxidative stress as a potential mechanism for initiating cardiovascular dysfunction.
| ||||||||||||||||||||||||
This article has been cited by other articles:
![]() |
E. Missel, G. S. Mintz, S. G. Carlier, J. Qian, S. Shan, C. Castellanos, R. Kaple, S. Biro, M. Fahy, J. W. Moses, et al. In vivo virtual histology intravascular ultrasound correlates of risk factors for sudden coronary death in men: results from the prospective, multi-centre virtual histology intravascular ultrasound registry Eur. Heart J., July 2, 2008; (2008) ehn293v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. N. Lang, I. J. Guthmundsdottir, N. A. Boon, C. A. Ludlam, K. A. Fox, and D. E. Newby Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers smoking, thrombin, and vascular responses in vivo. J. Am. Coll. Cardiol., July 1, 2008; 52(1): 33 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Edirisinghe, S.-R. Yang, H. Yao, S. Rajendrasozhan, S. Caito, D. Adenuga, C. Wong, A. Rahman, R. P. Phipps, Z.-G. Jin, et al. VEGFR-2 inhibition augments cigarette smoke-induced oxidative stress and inflammatory responses leading to endothelial dysfunction FASEB J, July 1, 2008; 22(7): 2297 - 2310. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mozaffarian, P. W.F. Wilson, and W. B. Kannel Beyond Established and Novel Risk Factors: Lifestyle Risk Factors for Cardiovascular Disease Circulation, June 10, 2008; 117(23): 3031 - 3038. [Full Text] [PDF] |
||||
![]() |
W. K. Al-Delaimy, M. J. Stampfer, J. E. Manson, and W. C. Willett Toenail Nicotine Levels as Predictors of Coronary Heart Disease among Women Am. J. Epidemiol., June 1, 2008; 167(11): 1342 - 1348. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Csiszar, N. Labinskyy, A. Podlutsky, P. M. Kaminski, M. S. Wolin, C. Zhang, P. Mukhopadhyay, P. Pacher, F. Hu, R. de Cabo, et al. Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2721 - H2735. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Heiss, N. Amabile, A. C. Lee, W. M. Real, S. F. Schick, D. Lao, M. L. Wong, S. Jahn, F. S. Angeli, P. Minasi, et al. Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production. J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1760 - 1771. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D O'Connell, J. M Nolan, J. Stack, D. Greenberg, J. Kyle, L. Maddock, and S. Beatty Diet and risk factors for age-related maculopathy Am. J. Clinical Nutrition, March 1, 2008; 87(3): 712 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Junyent, R. Gilabert, D. Zambon, M. Pocovi, M. Mallen, M. Cofan, I. Nunez, F. Civeira, D. Tejedor, and E. Ros Femoral Atherosclerosis In Heterozygous Familial Hypercholesterolemia: Influence Of The Genetic Defect Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 580 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Wakabayashi Associations of Alcohol Drinking and Cigarette Smoking with Serum Lipid Levels in Healthy Middle-Aged Men Alcohol Alcohol., February 18, 2008; (2008) agn005v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kifley, G. Liew, J. J. Wang, S. Kaushik, W. Smith, T. Y. Wong, and P. Mitchell Long-term Effects of Smoking on Retinal Microvascular Caliber Am. J. Epidemiol., December 1, 2007; 166(11): 1288 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zitt, B. Kollerits, U. Neyer, W. Mark, D. Heininger, G. Mayer, F. Kronenberg, and K. Lhotta Cigarette smoking and chronic allograft nephropathy Nephrol. Dial. Transplant., October 1, 2007; 22(10): 3034 - 3039. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Narkiewicz Second-hand smoke--a license to kill due to expire Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1508 - 1511. [Full Text] [PDF] |
||||
![]() |
S. S. Barbieri and B. B. Weksler Tobacco smoke cooperates with interleukin-1{beta} to alter {beta}-catenin trafficking in vascular endothelium resulting in increased permeability and induction of cyclooxygenase-2 expression in vitro and in vivo FASEB J, June 1, 2007; 21(8): 1831 - 1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. S. Park, J. Kim, Y. Misonou, R. Takamiya, M. Takahashi, M. R. Freeman, and N. Taniguchi Acrolein Induces Cyclooxygenase-2 and Prostaglandin Production in Human Umbilical Vein Endothelial Cells: Roles of p38 MAP Kinase Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1319 - 1325. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lavi, A. Prasad, E. H. Yang, V. Mathew, R. D. Simari, C. S. Rihal, L. O. Lerman, and A. Lerman Smoking Is Associated With Epicardial Coronary Endothelial Dysfunction and Elevated White Blood Cell Count in Patients With Chest Pain and Early Coronary Artery Disease Circulation, May 22, 2007; 115(20): 2621 - 2627. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Johnson, P. S. Douglas, S. R. Srinivasan, M. G. Bond, R. Tang, S. Li, W. Chen, G. S. Berenson, and J. H. Stein Predictors of Carotid Intima-Media Thickness Progression in Young Adults: The Bogalusa Heart Study Stroke, March 1, 2007; 38(3): 900 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Karatzi, C. Papamichael, E. Karatzis, T. G. Papaioannou, P. Th. Voidonikola, J. Lekakis, and A. Zampelas Acute Smoking Induces Endothelial Dysfunction in Healthy Smokers. Is This Reversible by Red Wine's Antioxidant Constituents? J. Am. Coll. Nutr., February 1, 2007; 26(1): 10 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Orosz, A. Csiszar, N. Labinskyy, K. Smith, P. M. Kaminski, P. Ferdinandy, M. S. Wolin, A. Rivera, and Z. Ungvari Cigarette smoke-induced proinflammatory alterations in the endothelial phenotype: role of NAD(P)H oxidase activation Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H130 - H139. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Y. Stokes NAD(P)H oxidase: where there's smoke, there's fire Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H119 - H120. [Full Text] [PDF] |
||||
![]() |
A. Avogaro and G. P. Fadini The Janus Face of Nicotinic Angiogenesis J. Am. Coll. Cardiol., December 19, 2006; 48(12): 2561 - 2563. [Full Text] [PDF] |
||||
![]() |
J R Payne, K I Eleftheriou, L E James, E Hawe, J Mann, A Stronge, P Kotwinski, M World, S E Humphries, D J Pennell, et al. Left ventricular growth response to exercise and cigarette smoking: data from LARGE Heart Heart, December 1, 2006; 92(12): 1784 - 1788. [Abstract] [Full Text] [PDF] |
||||
![]() |
K H Costenbader and E W Karlson Cigarette smoking and autoimmune disease: what can we learn from epidemiology? Lupus, November 1, 2006; 15(11): 737 - 745. [Abstract] [PDF] |
||||
![]() |
W.-Z. Zhang, K. Venardos, J. Chin-Dusting, and D. M. Kaye Adverse Effects of Cigarette Smoke on NO Bioavailability: Role of Arginine Metabolism and Oxidative Stress Hypertension, August 1, 2006; 48(2): 278 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bhargava, M. F. Weiner, L. S. Hynan, R. Diaz-Arrastia, and A. M. Lipton Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease. J Geriatr Psychiatry Neurol, June 1, 2006; 19(2): 78 - 82. [Abstract] [PDF] |
||||
![]() |
T M L Eagan, J Hetland, and L E Aaro Decline in respiratory symptoms in service workers five months after a public smoking ban Tob. Control, June 1, 2006; 15(3): 242 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Najem, A. Houssiere, A. Pathak, C. Janssen, D. Lemogoum, O. Xhaet, N. Cuylits, and P. van de Borne Acute Cardiovascular and Sympathetic Effects of Nicotine Replacement Therapy Hypertension, June 1, 2006; 47(6): 1162 - 1167. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Lee, K. E. North, M. S. Bray, M. Fornage, J. M. Seubert, J. W. Newman, B. D. Hammock, D. J. Couper, G. Heiss, and D. C. Zeldin Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study Hum. Mol. Genet., May 15, 2006; 15(10): 1640 - 1649. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kardys, C. C.W. Klaver, D. D.G. Despriet, A. A.B. Bergen, A. G. Uitterlinden, A. Hofman, B. A. Oostra, C. M. Van Duijn, P. T.V.M. de Jong, and J. C.M. Witteman A Common Polymorphism in the Complement Factor H Gene Is Associated With Increased Risk of Myocardial Infarction: The Rotterdam Study J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1568 - 1575. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Go, C. Iribarren, M. Chandra, P. V. Lathon, S. P. Fortmann, T. Quertermous, M. A. Hlatky, and for the Atherosclerotic Disease, Vascular Function Statin and beta-blocker therapy and the initial presentation of coronary heart disease. Ann Intern Med, February 21, 2006; 144(4): 229 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Heiss, T. Lauer, A. Dejam, P. Kleinbongard, S. Hamada, T. Rassaf, S. Matern, M. Feelisch, and M. Kelm Plasma Nitroso Compounds Are Decreased in Patients With Endothelial Dysfunction J. Am. Coll. Cardiol., February 7, 2006; 47(3): 573 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Shaw, C. N. Bairey Merz, C. J. Pepine, S. E. Reis, V. Bittner, S. F. Kelsey, M. Olson, B. D. Johnson, S. Mankad, B. L. Sharaf, et al. Insights From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: Gender Differences in Traditional and Novel Risk Factors, Symptom Evaluation, and Gender-Optimized Diagnostic Strategies J. Am. Coll. Cardiol., February 7, 2006; 47(3_Suppl_S): S4 - S20. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Perlstein and R. T. Lee Smoking, Metalloproteinases, and Vascular Disease Arterioscler. Thromb. Vasc. Biol., February 1, 2006; 26(2): 250 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Mitchell, J. A. Vita, M. G. Larson, H. Parise, M. J. Keyes, E. Warner, R. S. Vasan, D. Levy, and E. J. Benjamin Cross-Sectional Relations of Peripheral Microvascular Function, Cardiovascular Disease Risk Factors, and Aortic Stiffness: The Framingham Heart Study Circulation, December 13, 2005; 112(24): 3722 - 3728. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Walters, M. J. Paul-Clark, S. K. McMaster, K. Ito, I. M. Adcock, and J. A. Mitchell Cigarette Smoke Activates Human Monocytes by an Oxidant-AP-1 Signaling Pathway: Implications for Steroid Resistance Mol. Pharmacol., November 1, 2005; 68(5): 1343 - 1353. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Heiss, P. Kleinbongard, A. Dejam, S. Perre, H. Schroeter, H. Sies, and M. Kelm Acute Consumption of Flavanol-Rich Cocoa and the Reversal of Endothelial Dysfunction in Smokers J. Am. Coll. Cardiol., October 4, 2005; 46(7): 1276 - 1283. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Luchsinger, C. Reitz, L. S. Honig, M. X. Tang, S. Shea, and R. Mayeux Aggregation of vascular risk factors and risk of incident Alzheimer disease Neurology, August 23, 2005; 65(4): 545 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. van Grevenynghe, M. Bernard, S. Langouet, C. Le Berre, T. Fest, and O. Fardel Human CD34-Positive Hematopoietic Stem Cells Constitute Targets for Carcinogenic Polycyclic Aromatic Hydrocarbons J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 693 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bernhard, A. Csordas, B. Henderson, A. Rossmann, M. Kind, and G. Wick Cigarette smoke metal-catalyzed protein oxidation leads to vascular endothelial cell contraction by depolymerization of microtubules FASEB J, July 1, 2005; 19(9): 1096 - 1107. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Barnoya and S. A. Glantz Cardiovascular Effects of Secondhand Smoke: Nearly as Large as Smoking Circulation, May 24, 2005; 111(20): 2684 - 2698. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Strike and A. Steptoe Behavioral and Emotional Triggers of Acute Coronary Syndromes: A Systematic Review and Critique Psychosom Med, March 1, 2005; 67(2): 179 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lerman and A. M. Zeiher Endothelial Function: Cardiac Events Circulation, January 25, 2005; 111(3): 363 - 368. [Full Text] [PDF] |
||||
![]() |
Y Dargaud, C Pariset, L Pinede, L Rugeri, I Mohammedi, C Trzeciak, C Negrier, and J Ninet Multiple arterial thromboses in a patient with primary antiphospholipid syndrome receiving a bromocriptine therapy Lupus, December 1, 2004; 13(12): 957 - 960. [Abstract] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |